Asston Pharmaceuticals Limited IPO
SME BSEListed On: Jul 16, 2025 at ₹ 119.0
₹ 246000 /2000 Shares
*Min Investment
09 Jul, 2025
Open Date11 Jul, 2025
Close Date14 Jul, 2025
Allotment Date16 Jul, 2025
Listing DateAsston Pharmaceuticals IPO Issue Details
- Issue Price ₹115-123 per equity share
- Face Value ₹10 Per Equity Share
- Total Issue Size 22,41,000 shares(aggregating up to ₹27.56 crore)
- Fresh Share 22,41,000 shares(aggregating up to ₹27.56 crore)
- Listing at SME BSE
- List Price 119.0
- Listing Date 2025-07-16
- Lead Manager Sobhagya Capital Options Ltd
- Registrar Maashitla Securities Private Limited
Market Lot Size
Investors can bid for a minimum of 2000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 2 | 2000 | ₹2,46,000 |
| Retail(max) | 2 | 2000 | ₹2,46,000 |
| NII (min) | 3 | 3,000 | ₹3,69,000 |
Asston Pharmaceuticals IPO Reservation
Asston Pharmaceuticals IPO offers total 32,64,000 shares. Out of which NA (18.97%) allocated to QIB, 4,65,600 (14.26%) allocated to NII,10,86,400 (33.28%) allocated to RII, NA (NA%) allocated to employees and NA (28.43%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | NA (28.43%) | |
| Market Maker Shares Offered | NA (5.05%) | |
| QIB Shares Offered | NA (18.97%) | |
| NII (HNI) Shares Offered | 4,65,600 (14.26%) | |
| Retail Shares Offered | 10,86,400 (33.28%) | |
| Total Shares Offered | 32,64,000 (100%) |
Asston Pharmaceuticals IPO Details
Asston Pharmaceuticals Limited IPO is an SME IPO, priced at ₹115-123 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the SME BSE platform. The IPO comprises a total issue of 22,41,000 equity shares, aggregating up to ₹27.56 crores..
The IPO bidding window is open from Jul 9, 2025 to Jul 11, 2025. The allotment is expected to be finalized on Jul 14, 2025, and the tentative listing date is Jul 16, 2025.
The minimum lot size for Retail investors is 2000 shares, with a minimum investment of ₹2,46,000. For HNIs, the minimum application size is 3 lots , amounting to ₹ 3,69,000.
Sobhagya Capital Options Ltd is acting as the lead manager to the issue. The registrar of the IPO is Maashitla Securities Private Limited, and
Asston Pharmaceuticals IPO Subscription Analysis And Details
| As on | QIB | QIB / NII | NII bNII sNII | Retail | Total |
|---|---|---|---|---|---|
| Shares Offered / Reserved | 4,25,000 | 3,22,000 2,15,000 1,07,000 | 7,46,000 | 14,93,000 | |
Day 1 09-07-25 06:00 PM | 3.51 x | 0.66 0.00 x 0.00 x | 1.22 x | 1.75 x | |
Day 2 10-07-25 06:00 PM | 4.47 x | 19.67 19.29 x 21.50 x | 16.66 x | 13.84 x | |
Day 3 11-07-25 06:00 PM | 85.76 x | 353.14 424.47 x 210.85 x | 210.85 x | 186.55 x |
Asston Pharmaceuticals Valuations
Asston Pharmaceuticals Company Financials
| 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|
| Assets | 28.12 | 20.26 | 13.69 |
| Revenue | 25.61 | 15.84 | 7.19 |
| Profit After Tax | 4.33 | 1.36 | 1.06 |
| Net Worth | 10.72 | 6.39 | 1.99 |
| Reserves & Surplus | 4.45 | 5.61 | 1.29 |
| Total Borrowing | 7.26 | 6.82 | 5.25 |
About Asston Pharmaceuticals Company
Established in 2019, Asston Pharmaceuticals Limited is a pharmaceutical business dealing with the export of healthcare products worldwide.
The firm deals with a wide array of products like tablets, capsules, sachets, and syrups. Its product line covers different therapeutic classes like analgesics, antibiotics, antifungals, vitamins, etc.
The company makes direct sales medicines and also on a contract manufacturing or loan license, majorly operating on a principle-to-principle basis with different marketers.The company is certified by both State and Central FDA, NQA (Nuclear Quality Assurance) accredited, and adheres to Quality Management System (QMS) guidelines in terms of high-quality production.
Products:
Albendazole USP 400 mg: Albendazole USP 400 mg is a higher strength of Albendazole, a broad-spectrum anthelmintic (anti-worm) medication which is used for the treatment of different parasitic worm infections.
Diclofenac 100 mg: Diclofenac 100 mg is a particular strength of Diclofenac, a widely used nonsteroidal anti-inflammatory drug (NSAID).
Ibuprofen, paracetamol: Ibuprofen and Paracetamol (Acetaminophen) are two frequently used over-the-counter medications, typically used to relieve pain and decrease fever.
Ferrovit Syrup: For the management of vitamin and mineral deficiencies.
As of 3 July 2025, there are 46 Permanent staff and 6 contractual staff in the different departments.
Asston Pharmaceuticals - Promoter(s)
Dr. Ashish Narayan Sakalkar
Saili Jayaram More
Sachin Chandrakant Badakh
Pre Issue Share Holding : 68.76%
Post Issue Share Holding : 50.66%
Asston Pharmaceuticals IPO - Issue Objectives
Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
Funding the incremental working capital requirements of the Company
Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the Company
General Corporate Purposes
Contact Details
Asston Pharmaceuticals
4th Floor, Office No. A-431 Balaji Bhavan, Plot No 42A Sector-11 CBD Belapur, Navi Mumbai, Thane, Navi Mumbai, Maharashtra, 400614
+91 22 49731411
Registrar Contact Details
Maashitla Securities Private Limited
+91-11-45121795-96
Asston Pharmaceuticals IPO - FAQs
Ans. Asston Pharmaceuticals Limited IPO is a SME IPO. The issue is priced at ₹115-123 per equity share. The minimum order quantity is 1000 Shares. The IPO opens on Jul 9, 2025, and closes on Jul 11, 2025. Maashitla Securities Private Limited is the registrar for the IPO. The shares are proposed to be listed on SME BSE.
Ans. The Asston Pharmaceuticals Limited IPO opens on Jul 9, 2025 and closes on Jul 11, 2025.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Asston Pharmaceuticals Limited IPO is 22,41,000 shares(aggregating up to ₹27.56 Cr).
Ans. The Asston Pharmaceuticals Limited IPO price band is set between ₹115-123 per equity share.
Ans. To apply for Asston Pharmaceuticals Limited IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Asston Pharmaceuticals Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Asston Pharmaceuticals Limited IPO is Jul 14, 2025.
Ans. The Asston Pharmaceuticals Limited IPO will be listed on Jul 16, 2025.
Ans. Follow the steps to check the Asston Pharmaceuticals Limited IPO allotment status online.
